Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by Tson99on Jun 05, 2015 9:25am
169 Views
Post# 23800084

RE:Financing dilution vs partnership dilution

RE:Financing dilution vs partnership dilutionHey Beech,

What do you make of this?

https://www.trademarkia.com/oncocidin-85655515.html

This is a brand page for the ONCOCIDIN trademark by NOVAVIVE INC. in BELLEVILLE, ONTARIO, , K8N 4Z7. about a product or service associated with this ONCOCIDIN trademark. Or, contact the owner NOVAVIVE INC. of the ONCOCIDIN trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ONCOCIDIN trademark.
On Tuesday, June 19, 2012, a U.S. federal trademark registration was filed for ONCOCIDIN by NOVAVIVE INC., BELLEVILLE, ONTARIO K8N 4Z7. The USPTO has given the ONCOCIDIN trademark serial number of 85655515. The current federal status of this trademark filing is USPTO PLACED APPLICATION ON HOLD PENDING OTHER ACTION. The correspondent listed for ONCOCIDIN is Lori K. Hall of Gowling Lafleur Henderson LLP, One Main Street West, Hamilton, Ontario L8P4Z5 Canada . The ONCOCIDIN trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for ONCOCIDIN is immunostimulant for the therapeutic treatment of tumours in animals and humans.
<< Previous
Bullboard Posts
Next >>